Crane Company (CR) Q2 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2024 earnings summary
2 Feb, 2026Executive summary
Q2 2024 sales rose 14% year-over-year to $581 million, with adjusted EPS up 18% to $1.30 and operating profit up 53%, driven by strong core growth and recent acquisitions in Aerospace & Electronics and Process Flow Technologies.
Net income from continuing operations was $71.6 million, up 65.4% from Q2 2023.
Raised full-year adjusted EPS guidance midpoint by $0.15 to $4.95–$5.15, reflecting 18% growth at the midpoint.
Three acquisitions completed in the last year, including Vian Enterprises and CryoWorks, supporting segment expansion and margin growth.
Strong order growth and backlog, with core orders up 7% and backlog up 10% year-over-year, supporting continued momentum.
Financial highlights
Adjusted operating profit increased 22% year-over-year to $103 million; operating margin improved to 16.6% and adjusted margin to 17.7%.
Adjusted EBITDA for Q2 was $113 million, up 20% year-over-year; adjusted EBITDA margin at 20.5%.
Free cash flow for Q2 was $55–$57 million; full-year free cash flow expected at $255–$275 million with >90% conversion.
Total debt at quarter-end was $377 million, with $229 million cash on hand and over $1 billion in M&A capacity.
Net income margin for Q2 was 12.3%, up from 8.5% year-over-year.
Outlook and guidance
2024 full-year adjusted EPS guidance raised to $4.95–$5.15, reflecting 18% growth at midpoint.
Total sales growth expected at ~11%, with 5–7% core sales growth and 5% from acquisitions.
Adjusted segment operating profit expected to grow ~18%, about three times core sales growth.
Adjusted segment operating margin forecasted at ~20.7%.
Corporate expense guidance raised to $80 million, offset by lower non-operating expense and a slightly lower tax rate.
Latest events from Crane Company
- Q3 2025 delivered 7.5% sales growth, 27% higher EPS, and a raised full-year outlook.CR
Q3 20253 Feb 2026 - Record 2025 growth and acquisitions set up 10% adjusted EPS growth for 2026.CR
Q4 20252 Feb 2026 - Q3 2024 saw 13% sales growth, 34% higher EPS, and raised full-year guidance.CR
Q3 202418 Jan 2026 - Q4 adjusted EPS up 58%, sales up 12%, and 2025 guidance raised with a 12% dividend increase.CR
Q4 20249 Jan 2026 - Strong growth, margin expansion, and disciplined M&A set the stage for doubling business size.CR
Gabelli Funds 35th Annual Pump, Valve & Water Symposium7 Jan 2026 - Q1 2025 saw strong sales and profit growth, record backlog, and reaffirmed EPS guidance.CR
Q1 202525 Dec 2025 - Proxy details director elections, auditor ratification, and performance-based executive pay.CR
Proxy Filing1 Dec 2025 - Definitive additional proxy materials filed for shareholder voting with no fee required.CR
Proxy Filing1 Dec 2025 - Q2 sales up 9.2%, adjusted EPS up 24%, guidance raised, and major PSI acquisition announced.CR
Q2 20253 Nov 2025